Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients
Kathelijn Fischer(Utrecht University), Dietje E. Fransen van de Putte(Utrecht University), Pratima Chowdary(University College London), Karina Meijer(University Medical Center Groningen), Roger E. G. Schutgens(Utrecht University), Michael Makris(Royal Hallamshire Hospital), Peter W. Collins(Cardiff University), Goris Roosendaal(Utrecht University), Eveline P. Mauser‐Bunschoten(University Medical Center Utrecht)
Cited by 69
Related Papers
Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B
|Blood|2017|300
Clinical severity of haemophilia A: does the classification of the 1950s still stand?
|Haemophilia|2011|244
COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
|The Lancet Haematology|2021|237